Cargando…
The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
Background and Purpose: No previous study has compared the impact of dipyridamole-based triple antiplatelet therapy on secondary stroke prevention and long-term outcomes to that of dual antiplatelet therapy (DAPT) in patients with acute myocardial infarction (AMI) and previous stroke. This study aim...
Autores principales: | Wang, Mei-Tzu, Tsai, Cheng Ken, Kuo, Shu-Hung, Huang, Wei-Chun, Lin, Kun-Chang, Hung, Wang-Ting, Cheng, Chin-Chang, Tang, Pei-Ling, Hung, Cheng Chung, Yang, Jin-Shiou, Liang, Hsin-Li, Mar, Guang-Yuan, Liu, Chun-Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277508/ https://www.ncbi.nlm.nih.gov/pubmed/30538667 http://dx.doi.org/10.3389/fneur.2018.01003 |
Ejemplares similares
-
Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study
por: Wang, Mei-Tzu, et al.
Publicado: (2019) -
Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction – A 13-year nationwide cohort study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2019) -
Contribution of Hepatitis B to Long-Term Outcome Among Patients With Acute Myocardial Infarction: A Nationwide Study
por: Kuo, Pei-Lun, et al.
Publicado: (2016) -
Impact of hepatitis C virus infection on long-term mortality after acute myocardial infarction: a nationwide population-based, propensity-matched cohort study in Taiwan
por: Kuo, Shu-Hung, et al.
Publicado: (2018) -
Risk of Incident Epilepsy After a Middle Cerebral Artery Territory Infarction
por: Hsieh, Cheng-Yang, et al.
Publicado: (2022)